Piramal Pharma

PPLPHARMA21 May 2024
Pharmaceuticals
-1.20 (-0.80%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Piramal Pharma
Piramal Pharma
Pharmaceuticals
PPLPHARMA21 May 2024
-1.20 (-0.80%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Piramal Pharma - Share Price & Details

Lowest Today
147.85
Highest Today
151.5
Today’s Open
150.25
Prev. Close
149.5
52 Week High
166.7
52 Week Low
69.97
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
111.61%
Upper Circuit
Lower Circuit
P/E TTM
50.52
P/B Ratio
2.95
Traded Value(Cr)
0.00
EPS TTM
2.96
Book value
Dividend
0.00%

Price Performance

-3.05 %
1 Wk
5.39 %
1 M
11.19 %
3 M
111.61 %
1 Y
7.90 %
YTD

Traded Volume Movement

Technical Details

Support 3
144
Support 2
146
Support 1
147
Pivot Point :
150
Resistance 1
151
Resistance 2
153
Resistance 3
155

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Piramal Pharma Ltd
₹148.30(-1.20/-0.80%)
148.30-1.2019,778.07111.6150.522.95
Lupin Ltd
₹1,670.65(+10.35/0.62%)
1,670.65+10.3575,668.19113.0532.523.67
Ipca Laboratories Ltd
₹1,288.70(-21.05/-1.61%)
1,288.70-21.0533,228.9193.9960.415.36
J B Chemicals & Pharmaceuticals Ltd
₹1,806.05(-36.95/-2.00%)
1,806.05-36.9528,602.4083.6856.4310.65
Sanofi India Ltd
₹8,906.70(+37.45/0.42%)
8,906.70+37.4520,425.8838.6935.8220.02
373.85-2.402,208.79-12.9516.341.37

About Piramal Pharma Ltd

Piramal Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 19784.69 crores. It has reported a sales of Rs. 1525.3 crores and a net profit of Rs. 273.08 crores for the quarter ended December 2018. The company management includes Nandini Piramal, Nandini Piramal,PETER D DEYOUNG,Neeraj Bharadwaj,Jairaj Purandare,S Rama Dorai,Peter Stevenson,Sridhar Gorthi,Vibha Paul Rishi,Nathalie Leitch,Vivek Valsaraj,Tanya D'Costa (Piramal Pharma Ltd) among others.
Chairman
Nandini Piramal
Registered office
Ground Floor Piramal Ananta,Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra,400070
FAX :91-22-3802 3884
Background
Incorporation Year2020
Face Value₹10
Market Lot1

Latest News

📢 Benchmark indices open on a flat note today; Nifty near 22,500
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex lost 136.58 points or 0.18% at 73,869.36 and the Nifty was down 26.35 points or 0.12% at 22,475.65.
📢Zydus Life (⬆️5.00%), IEX (⬆️4.59%) and Hindustan Aeron(⬆️4.39%) appeared as the top performers on the Nifty50 at open. Astral Ltd., JSW Steel, and LIC Housing Fin. stocks are in focus today.
21 May 2024 | 09:22 AM
Nifty50, Nifty100 or Nifty500: Which index gives you the best diversity?
Recently, an asset management company (AMC) reduced the expense ratio—the proportion of fund assets to the outgo on administrative and other costs—of its index fund based on the Nifty500 by almost 60 percent. This got many fans of passive investing a bit excited and once again brought the topic of choice of indexing back into discussion.
21 May 2024 | 08:35 AM
📢 Benchmark indices open on a flat note today; Nifty near 22,500
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex lost 136.58 points or 0.18% at 73,869.36 and the Nifty was down 26.35 points or 0.12% at 22,475.65.
📢Zydus Life (⬆️5.00%), IEX (⬆️4.59%) and Hindustan Aeron(⬆️4.39%) appeared as the top performers on the Nifty50 at open. Astral Ltd., JSW Steel, and LIC Housing Fin. stocks are in focus today.
21 May 2024 | 09:22 AM
Ddev Plastiks Industries Q4 Results Live : profit falls by 27.64% YOY
Ddev Plastiks Industries Q4 Results: Ddev Plastiks Industries announced their Q4 results on 20 May, 2024, showcasing a 69.97% increase in revenue but a 27.64% decrease in profit compared to the same period last year. The company experienced a significant growth of 104.88% in revenue from the previous quarter, however, the profit saw a decline of 12.8%.
21 May 2024 | 01:31 PM
Rategain Travel Technologies Q4 Results: profit rise by 120.45% YOY
Rategain Travel Technologies Q4 Results: Rategain Travel Technologies declared their Q4 results on 21 May, 2024. The topline decreased by 35.74% & the profit increased by 120.45% YoY. Compared to the previous quarter, the revenue declined by 57.58% and the profit decreased by 6.14%. The Selling, general & administrative expenses declined by 73.91% q-o-q & decreased by 65.63% Y-o-Y.
21 May 2024 | 01:27 PM

How to buy Piramal Pharma shares on nse?

To buy Piramal Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Piramal Pharma share price today?

The Piramal Pharma shares price on nse is Rs.148.3 today.

What is the market cap of Piramal Pharma shares on NSE ?

The company has a market capitalization of Rs.19778.07Cr

What is the PE & PB ratio of Piramal Pharma shares ?

PE is 50.52 and PB is 2.95

What is the 52 Week High and Low of Piramal Pharma shares?

Piramal Pharma stock price high: Rs.166.7 Piramal Pharma stock price low: Rs.69.97

What can be the future price of Piramal Pharma shares on BSE?

The current price of Piramal Pharma on BSE is 71.51 (24 March 2023, 3:25 PM).

The future price of any shares on BSE, including those of Piramal shares are based on a variety of factors and these may lead to changes in the price of a stock at any time. The following factors must be considered while thinking of the future price of Piramal Pharma stocks: 

  • The position of the company in the pharmaceutical industry
  • Innovations of the company
  • Financial and overall company performance
  • Macroeconomic factors
  • Demand for pharmaceuticals
  • Competition

Is it safe to buy Piramal Pharma?

Piramal Pharma, a pharmaceutical company and part of the erstwhile Piramal Group, is a global business with a focus on providing innovative/integrated solutions across the total drug development and manufacturing value chain, right from drug discovery to the commercialisation of medicines. 

Whether a stock is safe to buy or not should be based on many factors like the financials of the company, the competition, the position of the company in the industry, macroeconomic factors and more. 

Nonetheless, the net sales of Piramal Pharma were at Rs. 6559 crores in March 2022, and the net profit was at Rs. 376 crores.

 

What is the current market value per shares of Piramal Pharma?

The current price of Piramal Pharma on BSE is 71.51 (24 April 2023, 3:25 PM).

Does Piramal Pharma have any debts?

As of 24 April 2023, Piramal Pharma has debt amounting to Rs. 5016 crores. 

Will Piramal Pharma shares price increase?

The ROI on Piramal Pharma stock is -65.32% (YTD). 

Determining whether share prices will increase depends on many factors like macroeconomic factors, the company’s performance, trends in the industry, the competition and other variables that influence stock prices frequently, besides on a long-term basis.

 

Should I buy or sell Piramal Pharma?

The 3-month returns on investment (ROI) of Piramal Pharma stock is -35.62%, and YTD is at -65.32%. 

Given this data, any stock’s movement depends on several factors which include: 

  • Company performance
  • Industry trends
  • Market trends
  • Competition
  • Demand and supply
  • Macroeconomic trends